Public Company News
Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy
SINGAPORE, Jan. 11, 2022 /PRNewswire/ -- MicroStrategy
2022-01-11 09:30
3277
Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of ASC42, An In-House Developed, Best-in-Class FXR Agonist for Chronic Hepatitis B Indication
HANGZHOU, China and SHAOXING, China, Jan. 11, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first patient in the Phase II clinical trial of ASC42 for chronic hepatitis B (CHB) indication. The Phase II clinical trial (ClinicalTrials.gov Identifier: NCT051...
2022-01-11 08:30
4321
Xaxis Uses IAS's Context Control Targeting to Raise Awareness for a Fashion Brand
TAIPEI, Jan. 11, 2022 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, and Xaxis, GroupM's outcome media specialist, used Context Control Targeting to increase campaign performance, website traffic, and brand awareness for a major fashion retailer, all ...
2022-01-11 08:00
3222
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
SEATTLE, SAN FRANCISCO, SAN JOSE, Calif., NANJING, China, SUZHOU, China and SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmace...
2022-01-11 05:30
5118
SKF acquires additive manufacturing company
GOTHENBURG, Sweden, Jan. 11, 2022 /PRNewswire/ -- SKF has completed the acquisition of Laser Cladding Venture n.v. (LCV), an additive manufacturing company based inBelgium. LCV is a niche engineering start-up specialized in various additive manufacturing technologies and processes, which can be ...
2022-01-11 00:15
4767
Buybacks of series B shares in AB Electrolux during week 01, 2022
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- During the period January 03 - January 07, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 342,312 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize ...
2022-01-10 22:56
2775
Everest Medicines Will Participate in a Clinical Trial with Gilead and MSD to Evaluate Trodelvy® in Combination with KEYTRUDA® (pembrolizumab) in First-Line Metastatic Non-Small Cell Lung Cancer
SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Everest Medicines
2022-01-10 21:35
5258
Invitation to Autoliv's Q4, 2021 Earnings Call
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- Autoliv Inc., plans to publish its Financial Report for the fourth quarter 2021 onFriday, January 28, 2022 at 12:00 Central European Time (CET). The report will be available at www.autoliv.com In addition, a teleconference will take place the same day. T...
2022-01-10 21:22
2849
Bigtincan Announces Bigtincan for Salesforce on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace
Bigtincan's customers can now benefit from a powerful recommendation engine WALTHAM, Mass., Jan. 10, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), a global leader in sales enablement automation, today announced the general availability of Bigtincan for Salesforce on Salesforce AppExchange, empoweri...
2022-01-10 21:12
2624
Clinical study on Bactiguard's endotracheal tube now published - shows significant reduction of ventilator-associated pneumonia
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care. The study shows a 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube. It was presented for th...
2022-01-10 20:57
2354
Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business
BOSTON and LAUSANNE, Switzerland, Jan. 10, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief B...
2022-01-10 20:28
3006
Clarivate Announces Change in Leadership Structure
LONDON, Jan. 10, 2022 /PRNewswire/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that as part of its One Clarivate Vision to put even greater focus on its customers and solutions, effectiveFebruar...
2022-01-10 20:00
2752
China Telecom's Annual Report Received 20 Gold Awards in Total Together with Two Grand Awards in International ARC Awards
HONG KONG, Jan. 10, 2022 /PRNewswire/ -- China Telecom Corporation Limited ("China Telecom" or "the Company"; HKEx: 00728; SSE: 601728) is pleased to announce that the print and online versions of its 2020 Annual Report " Digitalising the Future" received 11 gold awards in total in this year's In...
2022-01-10 17:21
6775
GoodWe rebrands, highlighting the role of smart tech in transforming the future of energy
SUZHOU, China, Jan. 10, 2022 /PRNewswire/ -- GoodWe has refreshed its brand in line with the evolution of the global new energy space, emphasizing on collaboration and digitalization. At the core of this new brand identity is GoodWe's commitment to harnessing smart tech to drive the global energy...
2022-01-10 16:30
4962
Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma Report also examines key therapeutic development areas to watch including mRNA, CRISPR, AI-driven drug discovery and more LONDON, Jan. 10, 2022 /...
2022-01-10 16:00
3354
JW Therapeutics Announces Two Appointments to Strengthen R&D Capability and Pipeline Building
SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, recently announced the appointments of Dr.Shaun Paul Cordoba as Chief Scientific Officer (...
2022-01-10 09:30
4615
Ascletis Announces U.S. IND Filing for In-House Developed Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors
HANGZHOU, China and SHAOXING, China, Jan. 10, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) announces today the filing of the U.S. Investigational New Drug (IND) application for in-house developed oral PD-L1 small molecule inhibitor, ASC61, for the treatment of advanced solid tumors. AS...
2022-01-10 08:30
4435
In the Era of the Boom of the Property Management Industry, Desun Services Adopts a Differentiated Approach
CHENGDU, China, Jan. 10, 2022 /PRNewswire/ -- Nowadays, property developers are taking on unprecedented challenges. Under the multiple control measures such as the Three Red Lines policy and centralized land supply, the development of property developers is once again put on hold, leaving the cap...
2022-01-10 07:59
6887
USI Plans to Mass-Produce IGBT and SiC Power Modules for Electric Vehicle Inverters in 2022
SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- With the rapid growth of the electric vehicle market, USI (SSE: 60131) has begun to lay out the assembly and testing of power modules for major international power semiconductor suppliers in recent years. Recently, USI won the favor of several European, Ame...
2022-01-10 07:00
4983
CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China
TIANJIN, China, Jan. 9, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that the National Medical Products Administration ofChina ("NMPA") granted approval for its ACYW135 Meningococcal Conjugate Vaccine (CRM197) ("MCV4", trade name: Menhycia™), ma...
2022-01-09 10:09
4771
Week's Top Stories
Most Reposted
Carro secures strategic investment from Orico
[Picked up by 293 media titles]
2026-09-18 16:29Agoda Begins Limited Public Beta of New AI Assistant That Turns Travel Ideas into Bookable Trips
[Picked up by 289 media titles]
2026-09-15 11:00
Avnet and The University of Hong Kong Open EMUS Lab to Accelerate AI Innovation and Commercialization in Hong Kong
[Picked up by 281 media titles]
2026-09-17 13:09
Tetra Pak and Soy Excellence Center Asia Host Regional Soy Food and Beverage Programme in Thailand
[Picked up by 268 media titles]
2026-09-18 11:51
Sovereign Investment Institutions Launch China-ASEAN Joint Investment Council
[Picked up by 267 media titles]
2026-09-16 09:09
Most Read
Agoda Begins Limited Public Beta of New AI Assistant That Turns Travel Ideas into Bookable Trips
2026-09-15 11:00
8928
QIVIKA to Launch Smart Scope on Kickstarter, Bringing a Professional Long-Range Experience to Day-and-Night Exploration
2026-09-12 09:00
8141
Temporal Raises $550 Million in Series E Round: NYSE Content Update
2026-09-14 21:14
7362
